Pathology Laboratory Equipment Market Size - By Product (Equipment, Disposables), By End-use (Diagnostic Centers, Hospitals) – Global Forecast to 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPathology Laboratory Equipment Market Size
Pathology Laboratory Equipment Market size was valued at USD 33 billion in 2022 and is estimated to account for USD 75 billion by 2032. The market refers to the industry involved in the manufacturing, distribution, and sale of various equipment and instruments used in pathology laboratories for disease analysis, diagnosis, and research.
This market includes a wide range of products such as microscopes, automated analyzers, sample processing systems, whole slide imaging systems, molecular diagnostic instruments, and cytology equipment. These tools are essential for examining specimens, performing tests, preparing samples, and visualizing diseases at a cellular and molecular level. The market serves hospital laboratories, reference laboratories, research institutions, and diagnostic centers. It is driven by factors such as technological advancements, increasing disease prevalence, research and development activities, and the need for accurate and efficient diagnostic tools.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Pathology Laboratory Equipment Market Size in 2022 | USD 33 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.5% |
| 2032 Value Projection | USD 75 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 210 |
| Tables, Charts & Figures | 351 |
| Segments covered | Product, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Technological advancements have revolutionized the field of pathology laboratory equipment, driving its growth and evolution. These advancements have significantly improved accuracy, efficiency, and diagnostic capabilities. For instances, advanced imaging systems, tissue diagnostics, automated analyzers, and molecular diagnostic instruments offer enhanced precision and sensitivity, leading to more accurate test results. Additionally, automation and robotics streamline workflows, reduce human error, and boost productivity.
For instance, Danaher Corporation's Leica Biosystems Bond Rx is an automated staining system specifically designed for immunohistochemistry and in situ hybridization in pathology laboratories. It provides reliable and consistent results, making it an essential tool for precise diagnostic testing and research purposes. Furthermore, the digitization of pathology slides and integration of digital pathology systems have facilitated remote access, collaboration, and telepathology consultations. This advancement not only expedites diagnosis but also enhances the ability to share and analyze digital images.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the pathology laboratory equipment market, leading to increased demand. The need for diagnostic testing and research on the virus drove a surge in demand for pathology laboratory equipment, such as automated analyzers, molecular diagnostic instruments, and sample processing systems. The adoption of digital pathology and remote viewing solutions became crucial for remote consultations and analysis, resulting in increased demand for digital imaging systems. The emphasis on biosafety measures also led to increased demand for biosafety cabinets and personal protective equipment in pathology laboratories.
Furthermore, the pandemic highlighted the importance of robust healthcare infrastructure and future preparedness, leading to investments in advanced pathology laboratory equipment. Therefore, the COVID-19 pandemic had a positive impact on the market, as it drove demand and spurred innovation in the industry.
Pathology Laboratory Equipment Market Trends
As chronic diseases like cancer, heart ailments, diabetes, and neurological conditions become more common worldwide, they're having a major impact on the market. A staggering 41 million people lose their lives to these noncommunicable diseases (NCDs) each year, accounting for around 74% of all deaths globally, according to the World Health Organization (WHO). Heart disease is the biggest killer among NCDs, claiming 17.9 million lives a year. Cancer isn't far behind, causing 9.3 million deaths, followed by chronic breathing problems (4.1 million deaths) and diabetes (2 million deaths), with kidney problems related to diabetes included in that figure.
These diseases pose a significant healthcare burden and require accurate diagnosis and monitoring for effective management. Pathology laboratory equipment, including imaging systems, molecular diagnostic tools, and automated analyzers, play a vital role in detecting and characterizing these diseases. Thus, the growing prevalence of chronic diseases fuels the demand for advanced equipment to facilitate timely and accurate diagnosis.
Pathology Laboratory Equipment Market Analysis
Imagine yourself stepping into a pathology lab, where you'll be greeted by a symphony of machines. There are incubators humming away, diligently tending to specimens. Laminar flow hoods are busy keeping the air pristine, while incredibly precise micro manipulation systems are delicately at work. You'll see centrifuges spinning at mind-boggling speeds, and air filtration systems tirelessly guarding the lab's environment. Scopes and sonicators peek into the tiniest details, revealing hidden treasures. Autoclaves and sterilizers stand ready to keep contamination at bay, and spectrophotometers and microarray equipment analyze the smallest of molecules. In 2022, this orchestra of equipment generated an impressive $21.4 billion. It's easy to see why. As more people fall ill and the need for accurate diagnoses grows, these machines are leading the charge. They incubate samples, sterilize instruments, and put doctors and researchers on the cutting edge of discovery. Thanks to technological breakthroughs, relentless research, and a generous flow of healthcare funding, this industry is booming. The promise of better diagnostics and healthier patients makes these machines indispensable stars in the pathology lab.
Based on end-use, the pathology laboratory equipment market is segmented into diagnostic centers, hospitals, and others. The diagnostic centers segment accounted for over 54% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. The diagnostic centers conduct a high volume of diverse diagnostic tests, requiring advanced equipment for accurate and timely results. Their focus on quality, collaboration, and personalized medicine drives the demand for pathology laboratory equipment. Additionally, the adoption of digital solutions in diagnostic centers further fuels the market growth.
U.S. pathology laboratory equipment market accounted for USD 12.6 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. The U.S. holds a dominant position in the market, driven by its advanced healthcare infrastructure, strong research and development capabilities, high disease burden, technological advancements, favourable reimbursement policies, and the presence of key market players. The U.S. population is experiencing a growing burden of chronic conditions such as cardiovascular disorders, cancer, diabetes, and chronic respiratory diseases.
For instances, according to the Centers for Disease Control and Prevention (CDC), a significant proportion of U.S. citizens, specifically 6 in 10 individuals, live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. These diseases require accurate and efficient diagnostic testing for timely treatment and management. Therefore, the rising prevalence of chronic diseases contributes to the demand for advanced pathology laboratory equipment in the U.S. healthcare system.
Pathology Laboratory Equipment Market Share
Some of the eminent market participants operating in the pathology laboratory equipment market include
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
- Agilent Technologies Inc.
- PerkinElmer Inc.
- Sartorius AG
- Shimadzu Corporation
- Thermo Fisher Scientific, Inc
- Waters Corporation
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
Pathology Laboratory Equipment Industry News
- In October 2022, Waters Corporation introduced the Extraction+ Connected Device, a software-controlled product designed for the automation of sample processing using solid phase extraction (SPE) in various applications such as biological, food, forensics, and environmental sample analysis. This innovative device worked seamlessly with the Waters Andrew+ Pipetting Robot, streamlining the extraction process for improved efficiency and accuracy, thereby promoting market growth.
- In June 2022, PerkinElmer, Inc. introduced the GC 2400 Platform, a state-of-the-art solution that combined automated gas chromatography (GC), headspace sampling, and GC/mass spectrometry (GC/MS) capabilities. This advanced platform was designed to assist laboratory teams in streamlining their operations and simplifying analytical workflows. Such innovative product launches boost business expansion.
Pathology laboratory equipment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product (USD Million & Units)
- Equipment
- Incubators
- Laminar flow hood
- Micro manipulation systems
- Centrifuges
- Lab air filtration system
- Scopes
- Sonicators and homogenizers
- Autoclaves and sterilizers
- Spectrophotometer and microarray equipment
- Others
- Disposables
- Pipettes
- Tips
- Tubes
- Cuvettes
- Dishes
- Gloves
- Masks
- Cell imaging consumables
- Cell culture consumables
By End-use (USD Million)
- Diagnostic centers
- Hospitals
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy